These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 14754614)
1. Second hit mutations in the RTK/RAS signaling pathway in acute myeloid leukemia with inv(16). Valk PJ; Bowen DT; Frew ME; Goodeve AC; Löwenberg B; Reilly JT Haematologica; 2004 Jan; 89(1):106. PubMed ID: 14754614 [No Abstract] [Full Text] [Related]
2. RAS, FLT3, and TP53 mutations in therapy-related myeloid malignancies with abnormalities of chromosomes 5 and 7. Side LE; Curtiss NP; Teel K; Kratz C; Wang PW; Larson RA; Le Beau MM; Shannon KM Genes Chromosomes Cancer; 2004 Mar; 39(3):217-23. PubMed ID: 14732923 [TBL] [Abstract][Full Text] [Related]
3. Pathogenesis of acute myeloid leukaemia and inv(16)(p13;q22): a paradigm for understanding leukaemogenesis? Reilly JT Br J Haematol; 2005 Jan; 128(1):18-34. PubMed ID: 15606546 [TBL] [Abstract][Full Text] [Related]
4. Clonality analysis of cell lineages in acute myeloid leukemia with inversion 16. Chang H; Nayar R; Li D; Sutherland DR Cancer Genet Cytogenet; 2005 Jan; 156(2):175-8. PubMed ID: 15642400 [TBL] [Abstract][Full Text] [Related]
5. A further case of acute myeloid leukaemia with inv(8)(p11q13) and MOZ-TIF2 fusion. Billio A; Steer EJ; Pianezze G; Svaldi M; Casin M; Amato B; Coser P; Cross NC Haematologica; 2002 May; 87(5):ECR15. PubMed ID: 12010678 [No Abstract] [Full Text] [Related]
6. Two more inv(16) acute myeloid leukemia cases with infrequent CBFbeta-MYH11 fusion transcript: clinical and molecular findings. Martinelli G; Ottaviani E; Buonamici S; Isidori A; Malagola M; Piccaluga P; Baccarani M Haematologica; 2002 May; 87(5):554-5. PubMed ID: 12010674 [No Abstract] [Full Text] [Related]
7. Morphologic characterization of acute myeloid leukemia with cytogenetic or molecular evidence of t(8;21), t(15;17), inv(16) and 11q23 abnormalities. Rozman M; Navarro JT; Domingo A; Ayats R; Vallespí T; Gallart M; Florensa L; Haematologica; 2002 Aug; 87(8):886-7. PubMed ID: 12161368 [No Abstract] [Full Text] [Related]
8. Mutations of N-RAS, FLT3 and p53 genes are not involved in the development of acute leukemia transformed from myeloproliferative diseases with JAK2 mutation. Suzuki M; Abe A; Kiyoi H; Murata M; Ito Y; Shimada K; Morishita Y; Kinoshita T; Naoe T Leukemia; 2006 Jun; 20(6):1168-9. PubMed ID: 16557239 [No Abstract] [Full Text] [Related]
10. Trisomy 22 as the sole abnormality is an important marker for the diagnosis of acute myeloid leukemia with inversion 16. Xu W; Zhou HF; Fan L; Qian SX; Chen LJ; Qiu HR; Zhang SJ; Li JY Onkologie; 2008 Sep; 31(8-9):440-4. PubMed ID: 18787351 [TBL] [Abstract][Full Text] [Related]
11. FLT3 mutations in myeloid sarcoma. Ansari-Lari MA; Yang CF; Tinawi-Aljundi R; Cooper L; Long P; Allan RH; Borowitz MJ; Berg KD; Murphy KM Br J Haematol; 2004 Sep; 126(6):785-91. PubMed ID: 15352981 [TBL] [Abstract][Full Text] [Related]
12. Acute myeloid leukemia with translocation (8;21) or inversion (16) in elderly patients treated with conventional chemotherapy: a collaborative study of the French CBF-AML intergroup. Prébet T; Boissel N; Reutenauer S; Thomas X; Delaunay J; Cahn JY; Pigneux A; Quesnel B; Witz F; Thépot S; Ugo V; Terre C; Recher C; Tavernier E; Hunault M; Esterni B; Castaigne S; Guilhot F; Dombret H; Vey N; ; ; J Clin Oncol; 2009 Oct; 27(28):4747-53. PubMed ID: 19720919 [TBL] [Abstract][Full Text] [Related]
14. A case of therapy-related acute myeloid leukemia associated with inv(16), with subsequent development of t(9;22). Kim M; Lim J; Kim Y; Han K; Kang CS; Kim HJ; Min WS Leukemia; 2006 Apr; 20(4):746-8. PubMed ID: 16437154 [No Abstract] [Full Text] [Related]
15. Acute myeloid leukaemia with FLT3 gene mutations of both internal tandem duplication and point mutation type. Chen W; Jones D; Medeiros LJ; Luthra R; Lin P Br J Haematol; 2005 Sep; 130(5):726-8. PubMed ID: 16115128 [TBL] [Abstract][Full Text] [Related]
16. Further evidence for a somatic KRAS mutation in a pilocytic astrocytoma. Janzarik WG; Kratz CP; Loges NT; Olbrich H; Klein C; Schäfer T; Scheurlen W; Roggendorf W; Weiller C; Niemeyer C; Korinthenberg R; Pfister S; Omran H Neuropediatrics; 2007 Apr; 38(2):61-3. PubMed ID: 17712732 [TBL] [Abstract][Full Text] [Related]
17. Risk assessment in patients with acute myeloid leukemia and a normal karyotype. Bienz M; Ludwig M; Leibundgut EO; Mueller BU; Ratschiller D; Solenthaler M; Fey MF; Pabst T Clin Cancer Res; 2005 Feb; 11(4):1416-24. PubMed ID: 15746041 [TBL] [Abstract][Full Text] [Related]
18. [Study of trisomy 22 and inversion 16 in acute myeloid leukemia]. Zhou HF; Li JY; Pan JL; Qiu HR; Chen LJ; Hu JY; Shen YF; Xu W; Xue YQ Zhonghua Xue Ye Xue Za Zhi; 2007 Jan; 28(1):11-4. PubMed ID: 17649718 [TBL] [Abstract][Full Text] [Related]
19. Molecular monitoring to identify a threshold of CBFbeta/MYH11 transcript below which continuous complete remission of acute myeloid leukemia inv16 is likely. Martinelli G; Rondoni M; Buonamici S; Ottaviani E; Piccaluga PP; Malagola M; Baccarani M Haematologica; 2004 Apr; 89(4):495-7. PubMed ID: 15075086 [TBL] [Abstract][Full Text] [Related]
20. Adverse prognostic significance of KIT mutations in adult acute myeloid leukemia with inv(16) and t(8;21): a Cancer and Leukemia Group B Study. Paschka P; Marcucci G; Ruppert AS; Mrózek K; Chen H; Kittles RA; Vukosavljevic T; Perrotti D; Vardiman JW; Carroll AJ; Kolitz JE; Larson RA; Bloomfield CD; J Clin Oncol; 2006 Aug; 24(24):3904-11. PubMed ID: 16921041 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]